Other
Stent Implantation
0
Pipeline Programs↗
2
Active Trials↗
1
Companies Involved↗
Stent Implantation is an early-stage landscape with 0 programs across 1 company. The most active players are Takeda.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
12
clinical trials
Unknown status7 · 58%
Completed2 · 17%
Not yet recruiting1 · 8%
Active, not recruiting1 · 8%
Terminated1 · 8%
Clinical Trials
Trial Activity
12 trials
Aroxxen® Inhalation for Cardioprotection After Elective PCI With Stent Implantation
Not yet recruiting·RResearch Institute of Geroprotective Technologies·Phase 2·NCT07397351·180 enrolled
Index of Microcirculatory Resistance After Drug-Eluting Stent Implantation With High Dose Atorvastatin Loading
Unknown status·—·N/A·NCT01491256·100 enrolled
Prevention for the Restenosis of Intracranial Artery Stent Implantation Treated With Herbal Medicine C117
Unknown status·GGuangzhou University of Traditional Chinese Medicine·Phase 2·NCT03008798·180 enrolled
Stent Implantation Versus Balloon Dilation for Acute Anterior Circulation Tandem Occlusion
Unknown status·—·N/A·NCT05902000·222 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)